:max_bytes(150000):strip_icc()/GettyImages-2282748371-3b15f552df2943a48d4f5566431b7689.jpg?#)
How Agios Pharmaceuticals' Shift Into Russell Growth Indices Will Impact Agios Pharmaceuticals (AGIO) Investors
In late June 2026, Agios Pharmaceuticals was added to several Russell growth benchmarks, including the Russell 2000 Growth, Russell 2500 Growth, Russell 3000E Growth, and Russell 3000 Growth, while being removed from certain value and defensive indices. This shift in index classification highlights how investors are increasingly viewing Agios as a growth-oriented biotech name, potentially increasing its exposure to growth-focused institutional and index-tracking funds. We’ll now examine how...
In late June 2026, Agios Pharmaceuticals was added to several Russell growth benchmarks, including the Russell 2000 Growth, Russell 2500 Growth, Russell 3000E Growth, and Russell 3000 Growth, while being removed from certain value and defensive indices.
This shift in index classification highlights how investors are increasingly viewing Agios as a growth-oriented biotech name, potentially increasing its exposure to growth-focused institutional and index-tracking funds.
We’ll now examine how...
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
